Report Details-
Global Automated Cell Cultures Market, By Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Others)-Industry Trends and Forecast to 2029.
Market Analysis and Size
One of the significant advantage of using automated cell culture is that it replaces the hours of repetitive manual work that has to be done by experienced personnel with instrumentation. This means that skilled laboratory technicians can be reorganized in areas of the business where their expertise is more valuable. Also it saves on the costs associated with this manpower and allows businesses to devote the resources to more cost-effective areas, such as research and development.
Data Bridge Market Research analyses that the automated cell cultures market was valued at USD 45.48 billion in 2021 and is further estimated to reach USD 90.36 billion by 2029, and is expected to grow at a CAGR of 8.96% during the forecast period of 2022 to 2029.
Market Definition
Automated cell culture systems are instruments that perform the tasks necessary for developing and maintaining a cell culture mechanically. An automated cell culture system can help develop cell cultures while saving labour time and reducing errors in any lab that works with cell biology, cell signalling, protein expression, or drug discovery.
Automated Cell Cultures Market Dynamics
Drivers
- Rise in the need of cell culture technology in vaccine production
Rising awareness regarding the advantages of cell-based vaccines. The rising global demand for innovative vaccines to limit and eradicate the coronavirus's spread, as well as tight safety regulations, have pushed researchers and manufacturers to produce automated cell culture-based vaccinations.
- Growing adoption of cell culture techniques in several applications
The growing demand for novel three-dimensional cell culture techniques in biopharmaceutical research and vaccine production has prompted the development of novel three-dimensional cell culture techniques.
- Increase in the government initiatives
Government activities in the form of funding are increasing, as the population increase.
Opportunities
In addition, the growing healthcare expenses, rise in the demand for 3D cell culture are further estimated to provide potential opportunities for the growth of the automated cell cultures market in the coming years.
Restraints/Challenges
On the other hand, the increased costs of cell biology research is further projected to impede the growth of the automated cell cultures market in the targeted period. However, the dearth of infrastructure for cell-based research in the advancing economies might further challenge the growth of the automated cell cultures market in the near future.
COVID-19 Impact on Automated Cell Cultures Market
The COVID-19 had a negative impact on the automated cell cultures market. Because research initiatives to generate COVID-19 vaccinations require cell lines, the COVID-19 pandemic is likely to shift the market in favour of automated cell culture systems. Demand for cell lines will continue to grow even after the right vaccine has been developed, as advances in this sector continue.
Researchers and producers have been driven to develop automated cell culture-based vaccinations due to rising global demand and tight safety regulations for innovative medicines to control and eradicate the coronavirus's spread. The need for automated cell culture products expanded dramatically as a result of this advancement.
Recent Development
- In May 2020, The Air Liquid Interface Culture System, in combination with pre-screened human bronchial epithelial cells, has been launched by PromoCell GmbH. The company will be able to create a repeatable human 3D airway model with a stable and predictable epithelial barrier function as a result of this.
- In April 2021, PPD, Inc. and Thermo Fisher Scientific Inc. have signed a formal agreement. According to the agreement, the corporation would pay USD 47.50 per share for PPD, Inc., for a total value of USD 17.4 billion. The agreement will assist the organisation in acquiring new skills and resources.
Global Automated Cell Cultures Market Scope and Market Size
The automated cell cultures market is segmented on the basis of product, type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
On the basis of product, the automated cell cultures market is segmented into consumables, instruments.
Type
- Infinite Cell Line Cultures
- Finite Cell Line Cultures
Based on type, the automated cell cultures market is divided into infinite cell line cultures, finite cell line cultures.
Application
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
- Vaccines
- Others
On the basis of application, the automated cell cultures market is divided into drug development, stem cell research, regenerative medicine, cancer research, vaccines, others.
End User
- Biotech Companies
- Research Organizations
- Academic Research Institutes
- Others
On the basis of end user, the automated cell cultures market is divided into biotech companies, research organizations, academic research institutes, others.
Automated Cell Cultures Market Regional Analysis/Insights
The automated cell cultures market is analysed and market size insights and trends are provided by country, product, type, application, and end user as referenced above.
The countries covered in the automated cell cultures market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The automated cell cultures market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for automated cell cultures market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the automated cell cultures market. The data is available for historic period 2010-2020.
Access Full Report:- https://www.databridgemarketresearch.com/reports/global-automated-cell-cultures-market
Competitive Landscape and Automated Cell Cultures Market Share Analysis
The automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to automated cell cultures market.
Some of the major players operating in the automated cell cultures market are:
Ø Sartorius AG (Germany)
Ø Danaher. (US)
Ø Lonza (Switzerland)
Ø Nexcelom Bioscience LLC. (US)
Ø HiMedia Laboratories (India)
Ø Cell Culture Company, LLC (US)
Ø Advanced Instruments (US)
Ø SHIBUYA CORPORATION (Japan)
Ø NanoEntek (South Korea)
Ø FUJIFILM Holdings America Corporation (US)
Ø Hitachi, Ltd. (US),
Ø Kawasaki Heavy Industries, ltd. (Japan)
Ø Sphere Fluidics Limited (UK)
Ø Thrive Bioscience (US)
Ø Eppendorf AG (Germany)
Ø CellGenix GmbH (Germany)
Ø ChemoMetec (Denmark)
Ø PromoCell GmbH (Germany)
Ø Thermo Fisher Scientific (US)
Ø BioSpherix, Ltd. (US)
Ø Merck KGaA (Germany)
Ø Tecan Trading AG (Switzerland)
Ø Hamilton Company (US)
Ø BD (US)
Ø Benchmark scientific, Inc. (US)
Ø Biotron Healthcare. (India)
Ø RWD Life Science Co., LTD (US)
Ø Corning Incorporated (US)
Ø Bulldog-Bio. (US)
Ø Sphere Fluidics Limited (UK)
Request Access for Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-automated-cell-cultures-market
Major TOC of the Report
· INTRODUCTION
· MARKET SEGMENTATION
· MARKET OVERVIEW
· EXECUTIVE SUMMARY
Get TOC of the Report:- https://www.databridgemarketresearch.com/toc/?dbmr=global-automated-cell-cultures-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
Global Dental 3D Printing Market
Global Genomic Biomarkers Market
Global In-Vitro Fertilization Services Market
Global Medical Lifting Sling Market
Global Vacuum-Assisted Biopsy Market
